SLC22A17 and breast cancer: Cancer cells of BC‐LM and LC‐LM make use of iron collection system LCN2/SLC22A17 to outcompete the macrophages, the major iron‐utilising cells, for sparse environmental iron, which promotes cancer cells growth and evades immune responses.8